Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000376897

Medchemexpress LLC Imatinib-d8 | 1092942-82-9 | C29H23D8N7O | 1 MG
SDP

Supplier:  Medchemexpress LLC HY15463S1MG

Encompass_Preferred

Imatinib-d8 is a deuterium-labeled variant of Imatinib (STI571), recognized as an orally bioavailable tyrosine kinase inhibitor. This compound is characterized by its selective inhibition of key kinase activities, specifically targeting BCR/ABL, v-Abl, PDGFR, and c-kit. It is exclusively designated for research applications and is not intended for human use.

  • Deuterium labeled compound
  • Orally bioavailable
  • Selectively inhibits BCR/ABL, v-Abl, PDGFR, and c-kit kinase activity
  • Can be utilized as a tracer in various studies
  • Serves as an internal standard for precise quantitative analysis via techniques such as NMR, GC-MS, or LC-MS

Catalog No. 50-003-76897


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.